Short-course Radiotherapy Combined With Neoadjuvant Chemotherapy and PD-1 Inhibitor in the Treatment of Locally Advanced Gastric Adenocarcinoma

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 26, 2022

Primary Completion Date

October 1, 2025

Study Completion Date

October 1, 2026

Conditions

Disorder in Complete Remission in Response to Treatment

Interventions

DRUG

Sintilimal Injection

Sintilimal (200mg) will be given i.v. on day 1 of each 3-week cycle.

Trial Locations (1)

RECRUITING

Renmin Hospital of Wuhan University, Wuhan

All Listed Sponsors

lead

Renmin Hospital of Wuhan University

OTHER